Why Do So Many Phase III Clinical Trials Fail?
December 6, 2022
Join the IDDI’s experts and learn on statistical explanations for a large proportion of Phase III clinical trials failures, and…
Webinars
Webinars
This series of scientific webinars is intended to provide methodology and knowledge related to clinical research.
IDDI has organized more than 25 scientific webinars so far.
All the recordings of our scientific webinars are available on:
IDDI Youtube Channel
IDDI Vimeo Channel
If you want to have access to the presentation of those webinars, please fill out the form in the section On-Demand Webinars.
Optimizing Rare Disease Trials: Trial Design & Execution
October 27, 2022
Join August Research and IDDI’s experts in the 60-minute complimentary webinar to gain insights into trial design and execution strategies…
The Benefit-Risk Assessment of New Treatments: The Health Technology Assessment (HTA) Process
September 22, 2022
September 22, 2022 | 5:00-6:00 PM CEST | 11:00 AM – 12:00 PM EDT ABSTRACT The increasing cost of new…
Conversation between a Sponsor and a Statistician about Phase II/III trials in oncology
June 23, 2022
Learn on the features, advantages and disadvantages of adaptive designs and group-sequential designs and their regulatory aspects of Phase II/III trials…
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
March 24, 2022 — March 24, 2022
This webinar presented the results of a new study that further demonstrated that risk-based monitoring is an efficient tool to…
Good Morning Meeting | Generalized Pairwise Comparisons (GPC): An innovative statistical method to design and analyze clinical trials
In collaboration with MVA, IDDI team is pleased to invite you to a Good Morning Meeting COPENHAGEN, DENMARK | APRIL…
Assessing treatment efficacy in early-phase oncology trials
February 3, 2022
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! THURSDAY, FEBRUARY 3 – 9:00 –…
Assessing activity in early-phase trials in oncology: current designs for expansion cohorts and phase 2
December 2, 2021
Be updated on different types of Bayesian and frequentist designs that may be used for expansion cohorts in phase 1…
ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
October 26, 2021
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…
Phase I trials in oncology: Pros and cons of current designs
October 21, 2021
Demystifying different types of Bayesian and frequentist designs that may be used for first-in-human or other types of phase I…